... The drug prevents HIV from attaching to and entering T cells, thereby blocking the infection process at a critical stage.Ibalizumab was first approved in 2018 for administration via an IV infusion, starting with a single loading dose (an initial high dose) followed by additional doses every two weeks. ...
Injectables for HIV Treatment and Prevention: How They Work
... The drug prevents HIV from attaching to and entering T cells, thereby blocking the infection process at a critical stage.Ibalizumab was first approved in 2018 for administration via an IV infusion, starting with a single loading dose (an initial high dose) followed by additional doses every two weeks. ...